The effect of supplementation on reducing depression in children with cancer

The effect of supplementation on reducing depression in children with cancer referred to the oncology ward of Bu Ali Sina Hospital in Sari

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190202042583N1

Enrollment

Registered

2020-08-14

Start date

2019-03-22

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in pediatric patients with malignancy. Mood disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: In addition to the standard treatment for depression, the group of patients with zinc deficiency will receive oral treatment with 10 mg of zinc gluconate daily at t

Eligibility

Sex/Gender

All

Age

7 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age between 7 to 18 years Having malignancy treated with chemotherapy Not more than one month has passed since the last round of chemotherapy Do not take antidepressants of any category during the past month Do not take zinc supplements or other supplements containing zinc compounds during the past month Satisfaction to test the serum level by taking a blood sample Regular use of antidepressants or zinc supplements

Exclusion criteria

Exclusion criteria: Congenital diseases of zinc metabolism such as acrodermatitis enteropathy, chronic inflammatory bowel disease, malabsorption syndromes

Design outcomes

Primary

Measure	Time frame
Depression score based on the Mariaquas Children Depression Inventory "CDI". Timepoint: day 30. Method of measurement: CDI test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohmmad Naderi Soraki

Mazandaran University of Medical Sciences

dr.naderisorki@mazums.ac.ir+98 11 3304 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026